We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > dengue fever

News List

Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts worldpharmanews
June 24, 2021
Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines.
Dengvaxia Vaccine Approved for Prevention of Dengue in Europe americanpharmaceuticalreview
December 20, 2018
The European Commission has granted marketing authorization for Dengvaxia, Sanofi's dengue vaccine. The marketing authorization follows the October 18, 2018......
Sanofi's controversial Dengvaxia picks up FDA priority review fiercepharma
November 09, 2018
Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead, and on Tuesday said the FDA had not only accepted
Abivax to screen new antiviral molecules to develop therapeutic candidates against dengue fever pharmaceutical-technology
February 27, 2017
French biotechnology company Abivax has discovered new antiviral molecules and is screening them to develop therapeutic candidates against dengue fever.